A randomised clinical trial to determine the relative benefits of botulinum toxin injections, ankle foot orthosis or a combination of both on knee hyperextension during walking in people with chronic stroke.
- Conditions
- Knee hyperextension in stancePeople with strokeStroke - Haemorrhagic
- Registration Number
- ACTRN12609000034235
- Lead Sponsor
- Clinical Gait Analysis Service
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
People with stroke affecting one side of the body;
Passive dorsiflexion less than plantigrade;
dynamic range of gastrocnemius greater than 15 degrees;
knee hyperextension more than 0 degrees in mid-stance;
able to walk more than 400 metres without assistance;
agree to injections +/- ankle foot orthosis
agree to repeat assessments.
Participants will have no other neurological, cardiothoracic, orthopaedic or psychological condition affecting walking ability. Other exclusion criteria include: incompetence to provide informed consent; known contraindications to botulinum toxin, including sensitivity, infection and pregancy; participants who have received BoNT-A or phenol injections for the treatment of increased tone within the previous 6 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method